These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 9255285

  • 1. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vessella RL.
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [Abstract] [Full Text] [Related]

  • 2. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF, Gottenger E, Nguyen C, Song W, Kattan MW, Andenoro J, Wheeler TM, Spencer DM, Slawin KM.
    Cancer Res; 2002 Oct 15; 62(20):5974-9. PubMed ID: 12384565
    [Abstract] [Full Text] [Related]

  • 3. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
    Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM.
    Cancer Res; 2000 Dec 15; 60(24):7142-8. PubMed ID: 11156423
    [Abstract] [Full Text] [Related]

  • 4. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG, Raj GV, Moreno JG.
    J Urol; 1997 Aug 15; 158(2):326-37. PubMed ID: 9224297
    [Abstract] [Full Text] [Related]

  • 5. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N, Saporta F, Flam TA, Pages F, Zerbib M, Vieillefond A, Martin E, Debré B, Chevillard S.
    Urology; 1997 Aug 15; 50(2):245-50. PubMed ID: 9255296
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
    Shariat SF, Roudier MP, Wilcox GE, Kattan MW, Scardino PT, Vessella RL, Erdamar S, Nguyen C, Wheeler TM, Slawin KM.
    Cancer Res; 2003 Aug 01; 63(15):4662-70. PubMed ID: 12907647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY, Seay T, Hogen K, Charlesworth MC, Roche PC, Klee GG, Tindall DJ.
    Prostate Suppl; 1996 Aug 01; 7():17-24. PubMed ID: 8950360
    [Abstract] [Full Text] [Related]

  • 10. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
    Lintula S, Stenman J, Bjartell A, Nordling S, Stenman UH.
    Prostate; 2005 Jun 01; 63(4):324-9. PubMed ID: 15599939
    [Abstract] [Full Text] [Related]

  • 11. Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.
    Mabjeesh NJ, Amir S, Stenger A, Chen J, Matzkin H.
    Prostate; 2009 Aug 01; 69(11):1235-44. PubMed ID: 19434652
    [Abstract] [Full Text] [Related]

  • 12. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L, Ferruelo A, Luján M, Pascual C, García-Mediero JM, Berenguer A.
    Prostate Cancer Prostatic Dis; 2005 Aug 01; 8(3):248-52. PubMed ID: 15897916
    [Abstract] [Full Text] [Related]

  • 13. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
    de Cremoux P, Ravery V, Podgorniak MP, Chevillard S, Toublanc M, Thiounn N, Tatoud R, Delmas V, Calvo T, Boccon-Gibod L.
    Eur Urol; 1997 Aug 01; 32(1):69-74. PubMed ID: 9266235
    [Abstract] [Full Text] [Related]

  • 14. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM.
    Cancer Res; 2003 Sep 15; 63(18):5874-8. PubMed ID: 14522912
    [Abstract] [Full Text] [Related]

  • 15. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 16. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
    Okubo Y, Ito T.
    Hinyokika Kiyo; 1999 Jan 15; 45(1):25-30. PubMed ID: 10086262
    [Abstract] [Full Text] [Related]

  • 17. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y.
    Clin Cancer Res; 2002 Jun 15; 8(6):1794-9. PubMed ID: 12060619
    [Abstract] [Full Text] [Related]

  • 18. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2000 Apr 15; 163(4):1183-8. PubMed ID: 10737491
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.